DIS3L2 and neoplasm: Astuti and colleagues showed that the loss of DIS3L2 is associated with mitotic abnormalities and the abnormal expression of mitotic proteins, introducing the tumor suppressor activity of DIS3L2 (Astuti et al., 2012).